All In Biotech

Drug Trial Radar · NCT06683651

A Study in Chinese Patients With Acquired Blepharoptosis

A Multicenter, Randomized, Double-Masked, Placebo-Controlled Parallel Group Phase III Study to Evaluate the Efficacy and Safety of STN1013800 Ophthalmic Solution in Chinese Patients With Acquired Blepharoptosis

Last checked: Nov 20, 2026Latest source record: May 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 180 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

180

Planned (sponsor's estimate)

Start

Oct 22, 2024

Primary completion

Jun 2026

Study completion Jun 2026

Sponsor

Sponsor type
Industry
First posted
Nov 12, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase III Study to evaluate the efficacy and safety of STN1013800 Ophthalmic Solution in Chinese Patients with Acquired Blepharoptosis. At present, there are no medicines for the treatment of acquired blepharoptosis in China. Therefore, to evaluate the efficacy and safety of 0.1% STN1013800 ophthalmic solution, Vehicle (Placebo) are designed. For the screening period, 3-7 days were set to confirm the subjects and judge their qualification. Dosage and administration were based on prior clinical trial results approved at 0.1% once daily for 42 days treatment.

Conditions

  • Blepharoptosis

Interventions

  • STN1013800 ophthalmic solutionDrug

    Investigational Product: 0.1% STN1013800 ophthalmic solution

  • STN1013800 ophthalmic solution Liquid Base, without STN1013800Drug

    Placebo control: STN1013800 ophthalmic solution Liquid Base, without STN1013800

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change from Baseline in the STN1013800 group versus the Vehicle (Placebo) groupTime frame: Day 1 Hour 6 (Visit 2); Day 14 Hour 2 (Visit 3)

Locations

23 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Luhe Hospital, Capital Medical University

    Beijing, China · Recruiting

  • Anhui Provincial Hospital

    Hefei, Anhui, China · Recruiting

  • The Second Hospital of Anhui Medical University

    Hefei, Anhui, China · Recruiting

  • Beijing Chaoyang Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong

    Shantou, Guangdong, China · Recruiting

  • Affiliated Hospital of Guizhou Medical University

    Guiyang, Guizhou, China · Recruiting

  • The first affiliated hospital of Zhengzhou University

    Zhengzhou, He'nan, China · Recruiting

  • The 2nd Affiliated Hospital of Harbin Medical University

    Ha’erbin, Helongjiang, China · Recruiting

  • Wuhan Aier Eye Hospital

    Wuhan, Hubei, China · Recruiting

  • Xiangyang Central Hospital

    Xiangyang, Hubei, China · Recruiting

  • Nanjing First Hospital

    Nanjing, Jiangsu, China · Recruiting

  • The second norman bethune hospital of Jilin University

    Changchun, Jilin, China · Recruiting

  • Dalian No.3 Peple's Hospital

    Dali, Liaoning, China · Recruiting

  • The 4TH People's Hospital of Shenyang

    Shenyang, Liaoning, China · Recruiting

  • The affiliated People's Hospital of Ningbo

    Zhenjiang, Ningbo, China · Recruiting

  • Shandong Eye Hospital

    Jinan, Shandong, China · Recruiting

  • Eye & Ent Hospital of Fudan University

    Shanghai, Shanghai Municipality, China · Recruiting

  • Shanxi Eye Hospital

    Taiyuan, Shanxi, China · Recruiting

  • Panzhihua Hospital of Integrated Chinese and Western Medicine

    Panzhihua, Sichuan, China · Recruiting

  • Tianjin Eye Hospital

    Tianjin, Tianjin Municipality, China · Recruiting

  • Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China · Recruiting

  • The First Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China · Recruiting

  • Eye Hospital, Wenzhou Medical University / Zhejiang Eye Hospital

    Wenzhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.